Anfield Capital Management’s Amgen AMGN Stock Holding History

Anfield Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.46K	Sell	7 -70	-91%	-$25K	﹤0.01%	570
2025 Q4	$25.2K	Buy	77 +70	+1,000%	+$22.2K	0.01%	242
2025 Q3	$1.98K	Buy	7 +3	+75%	+$870	﹤0.01%	480
2025 Q2	$1.12K	Hold	4	–	–	﹤0.01%	473
2025 Q1	$1.25K	Hold	4	–	–	﹤0.01%	410
2024 Q4	$1.04K	Hold	4	–	–	﹤0.01%	400
2024 Q3	$1.29K	Hold	4	–	–	﹤0.01%	396
2024 Q2	$1.25K	Buy	+4	New	+$1.18K	﹤0.01%	348
2021 Q3	–	Sell	-44	Closed	-$11K	–	138
2021 Q2	$11K	Buy	+44	New	+$10.8K	﹤0.01%	161
2020 Q3	–	Sell	-2,429	Closed	-$594K	–	68
2020 Q2	$594K	Buy	2,429 +44	+2%	+$10K	0.23%	54
2020 Q1	$484K	Buy	2,385 +221	+10%	+$48.3K	0.28%	65
2019 Q4	$502K	Buy	+2,164	New	+$477K	0.2%	77

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Anfield Capital Management's AMGN Position: Q1 2026 in Review

Anfield Capital Management reduced its Amgen (AMGN) stake by 91% in Q1 2026, selling an estimated $25K and leaving 7 shares worth $2.46K. The position accounts for ﹤0.01% of the portfolio, ranked #570.

Anfield Capital Management first reported a position in AMGN in Q4 2019 and has held it in 12 quarters since. The position peaked at $594K in Q2 2020. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Anfield Capital Management held 7 shares of Amgen worth $2.46K as of Q1 2026.
Anfield Capital Management sold 70 Amgen shares in Q1 2026, an estimated $25K.
Amgen made up ﹤0.01% of Anfield Capital Management's portfolio in Q1 2026, its #570 holding.
Anfield Capital Management first reported a position in Amgen in Q4 2019 and has held it in 12 quarters since.
Anfield Capital Management's Amgen position peaked at $594K in Q2 2020.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.